{
  "ptid_time": "070_S_4719_2012-05-21",
  "img_path": "/data/qiuhui/data/adni/images/070_S_4719/2012-05-21/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 43,518 mm³, 55.0% above the reference mean. With a Z-score of 1.26 (89.6th percentile), this represents mild enlargement; whole brain volume measures 884,811 mm³, 9.2% below the reference mean. With a Z-score of -1.16 (12.3th percentile), this represents mild atrophy. ",
  "text_data": "Age is 79.1 years. Gender is Female. Education: 16 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Endocrine-Metabolic; Gastrointestinal; Hematopoietic-Lymphatic; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 22.0. MoCA: 12.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.43 SUVR (significant elevated); Amyloid beta: 649.30 pg/mL (normal ); Total tau: 312.10 pg/mL (normal ); Phosphorylated tau: 29.72 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows mild ventricular enlargement and mild whole brain atrophy, which are structural changes often seen in neurodegenerative conditions. The cognitive scores (MMSE: 22, MoCA: 12) indicate significant cognitive impairment, while biomarker data (elevated P-tau and AV45, normal Aβ) suggest Alzheimer's pathology despite normal Aβ levels (possible tau-predominant or atypical AD).  \n\n**Diagnosis:** **Dementia** (likely Alzheimer’s disease variant, given tau/PET findings and cognitive decline).  \n\n**Confidence:** **Medium** (clear cognitive impairment and biomarker support, but atypical Aβ profile warrants caution).",
  "timestamp": "2025-07-26T09:03:57.055306"
}